O. Lindén

Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma

Franck Morschhauser, Paula Marlton, Umberto Vitolo et al. · Annals of Oncology · 2010 · 144 citations · Full text

Medicine, Hematology, Pharmacology +15

Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study

Henna Riikka Junlén, Stefan Peterson, Eva Kimby et al. · Leukemia · 2014 · 132 citations

Medicine, Geriatric Medicine, Oncology +10

Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas.

O. Lindén, Jan Tennvall, Eva Cavallin‐Ståhl et al. · PubMed · 1999 · 46 citations

Medicine, Nuclear Medicine, Oncology +17

The development of spasticity with age in 4,162 children with cerebral palsy: a register-based prospective cohort study

O. Lindén, Gunnar Hägglund, Elisabet Rodby‐Bousquet et al. · Acta Orthopaedica · 2019 · 45 citations · Full text

Education, Child Health, Pediatrics +13

Functions of rat CD4+ T cell subsets defined by CD45RB: CD45RB− cells have a much stronger response to recall antigens, whereas polyclonally activated cells of both subsets are equally efficient producers of IFN in the presence of exogenous IL-2

Peter Ericsson, O. Lindén, Mikael Dohlsten et al. · Cellular Immunology · 1991 · 17 citations

Life Sciences, Cell Biology, Immunology +15